Lindsay Rosenwald, Pres, CEO & COB, Director, Ten Percent Owner at Fortress Biotech, holds 3.66M shares in Fortress Biotech (Ticker: FBIO), holds 330.44K shares in Journey Medical Corp (Ticker: DERM), holds 132.17K shares in Checkpoint Therapeutics (Ticker: CKPT). Most recently, Lindsay Rosenwald Bought ― shares of Fortress Biotech on Sep 25, 2024 for an estimated value of 1.40M.
Lindsay Rosenwald latest transaction was an Informative Buy of $1.40M.
What was Lindsay Rosenwald's most profitable transaction?
Lindsay Rosenwald’s most profitable transaction was an Informative Buy of FBIO stock on November 10, 2014. The return on the trade was 101.90%.
What is Lindsay Rosenwald's role in Fortress Biotech?
Lindsay Rosenwald's role in Fortress Biotech is Pres, CEO & COB, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.